氯吡格雷对PCI TXB2 6-K-PGF1α和PTINR的干预影响
出处
《浙江临床医学》
2007年第6期757-757,共1页
Zhejiang Clinical Medical Journal
参考文献4
-
1张建维,贾三庆.氯吡格雷在冠心病介入治疗中的应用进展——氯吡格雷抵抗[J].中国医刊,2006,41(3):44-47. 被引量：3
-
2任宏生,朱兴雷.氯吡格雷防治动脉粥样硬化缺血性疾病的研究进展[J].心血管病学进展,2006,27(3):274-281. 被引量：29
-
3吴桂萍,李田昌.氯吡格雷研究的最新进展[J].临床荟萃,2006,21(7):516-519. 被引量：59
-
4陈凌,李志善,戚文航,范维琥,王林.硫酸氯吡格雷的抗血小板聚集临床研究[J].中国新药杂志,2000,9(10):715-717. 被引量：10
二级参考文献88
-
1Steinhubl SR,Berger PB,Mann JT 3rd,et al.Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention:a randomized controlled trial[J].JAMA,2002,288:2411-2420.
-
2Soffer D,Moussa I,Harjai KJ,et al.Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention:do we need more aggressive dosing regimens in unstable angina?[J].Catheter Cardiovasc Interv,2003,59:21-25.
-
3Fontana P,Dupont A,Gandrille S,et al.Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects[J].Circulation,2003,108:989-995.
-
4Gurbel PA,Bliden KP.Durability of platelet inhibition by clopidogrel[J].Am J Cardiol,2002,92:1123-1125.
-
5Kereiakes DJ.Adjunctive pharmacotherapy before percutaneous coronary intervention in non-ST-elevation acute coronary syndromes:the role of modulating inflammation[J].Circulation,2003,108;III-22-III-27.
-
6Patti G,Colonna G,Pasceri V,et al.Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention:results from the ARMYDA-2 (Antiplatelet therapy for Reduction of my ocardial Damage during Angioplasty) study[J].Circulation,2005,111(16):2099-2106.
-
7Gum PA,Kottke-Marchant K,Poggio ED,et al.Profile and prevalence of aspirin resistance in patients with cardiovascular disease[J].Am J Cardiol,2001,88:230-235.
-
8Angiolillo DJ,Fernandez-Ortiz A,Bernardo E,et al.Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting[J].Thromb Res,2005,115:101-108.
-
9Klinkhardt U,Graff J,Harder S.Clopidogrel,but not abciximab,reduces platelet leukocyte conjugates and P-selectin expression in a human ex vivo in vitro model[J].Clin Pharmacol Ther,2002,71:176-185.
-
10Matetzky S,Shenkman B,Guetta V,et al.Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction[J].Circulation,2004,109:3171-3175.
共引文献95
-
1刘金敬,李丰升,聂忆秋.氯吡格雷治疗中青年脑梗死的疗效观察[J].医学信息（医学与计算机应用）,2014,0(12):230-231.
-
2刘璇,黄雪珊.氯吡格雷对异种移植心脏急性血管性排斥反应的影响[J].福建医科大学学报,2006,40(6):572-574.
-
3张湧,沈无明,梁建军.国产氯吡格雷在经皮急诊冠状动脉介入治疗患者中应用的疗效观察[J].中国医学前沿杂志（电子版）,2013,5(2):74-77. 被引量：5
-
4张娆.氯吡格雷治疗中青年脑梗死的临床疗效分析[J].中国医学前沿杂志（电子版）,2013,5(9):74-76.
-
5吴金家,陈爱华,李志梁,刘映峰,肖华.高龄患者在冠状动脉支架植入术后抗凝的临床观察[J].岭南心血管病杂志,2005,11(4):268-269.
-
6杨翠娈,石家庆.氯吡格雷联合低分子肝素钙治疗短暂性脑缺血发作的临床观察[J].广西医科大学学报,2010,27(6):913-914. 被引量：13
-
7徐崇利,李春坚,王连生,杨志健,陈波.氯吡格雷用于动脉粥样硬化血栓栓塞性疾病的安全性和耐受性观察[J].中西医结合心脑血管病杂志,2006,4(11):947-948. 被引量：1
-
8冯媛,刘敏,季曙明.氯吡格雷对肾移植患者血小板CD40L等炎症因子表达的影响[J].现代生物医学进展,2006,6(11):46-49. 被引量：2
-
9韩志武,李靖,王芳,徐友平,姚国乾.氯吡格雷用于尿毒症动静脉内瘘术后维护的疗效观察[J].内科急危重症杂志,2007,13(3):164-164. 被引量：10
-
10桂亮,吴晓琴.氯吡格雷治疗急性冠脉综合征疗效观察的报告[J].中国社区医师（医学专业）,2007,9(16):47-47.
-
1洪广秋,季乃军,梅益斌,王成尧,陈东海.阿斯匹林对原发性高血压患者血清血栓素B_2、6-酮-前列腺素F_(1α)和PTINR的影响[J].浙江中医学院学报,2003,27(6):29-30. 被引量：3
-
2周衍国,麦瑞林,孙正芳,章帮秀,肖平平.探讨冠心病合并糖尿病患者血糖控制前后同型半胱氨酸及凝血功能变化[J].现代诊断与治疗,2013,24(9):2131-2132. 被引量：1
-
3李慧,杨守忠,李玉东,卢才义.华法令预防非瓣膜病心房颤动血栓栓塞的临床研究[J].医学信息（西安上半月）,2005,18(8):961-962. 被引量：1
-
4吴晓春,季乃军,胡昌盛,童丽军.阿司匹林对老年冠心病患者TxB_2、6-K-PGF_(1α)和PTINR的干预影响[J].临床医学,2007,27(6):88-89.
-
5谷亦明,于胜泳,吕先念.国产氯吡格雷治疗不稳定型心绞痛合并代谢综合征[J].中西医结合心脑血管病杂志,2011,9(7):885-886. 被引量：3
-
6雷振海.通心络对原发性高血压患者血清血栓素B_2、6-酮-前列腺素F_(1α)的干预影响[J].现代中西医结合杂志,2005,14(17):2252-2253. 被引量：1
-
7季乃军,梅益斌,等.阿司匹林对冠心病患者血清TXB2、6—K—PGF1α和PTINR的干预影响[J].天津药学,2001,13(B12):17-18.
-
8贺立群,雷健,王顺,李佐民,昌薇,张帆,冷沁.他汀治疗对冠状动脉慢血流患者血清可溶性E-选择素、hs-CRP水平的影响[J].内科急危重症杂志,2014,20(5):313-314. 被引量：5
-
9林爱玲,朱苗飞,廖梅芳.冠心病介入治疗术后股动脉穿刺部位的观察和护理[J].基层医学论坛,2006,10(8):750-751. 被引量：4
-
10何奔.冠心病介入治疗术后的药物治疗[J].家庭用药,2009(1):16-16.
